Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion type Assertion NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_head.
- NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_provenance.
- NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion evidence source_evidence_literature NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_provenance.
- NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion SIO_000772 20237142 NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_provenance.
- NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion wasDerivedFrom befree-20150227 NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_provenance.
- NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion wasGeneratedBy ECO_0000203 NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_provenance.